Oral Bioavailability of Insulin Contained in Polysaccharide Nanoparticles
Citations Over TimeTop 10% of 2007 papers
Abstract
The pharmacological activity of insulin-loaded dextran sulfate/chitosan nanoparticles was evaluated following oral dosage in diabetic rats. Nanoparticles were mucoadhesive and negatively charged with a mean size of 500 nm, suitable for uptake within the gastrointestinal tract. Insulin association efficiency was over 70% and was released in a pH-dependent manner under simulated gastrointestinal conditions. Orally delivered nanoparticles lowered basal serum glucose levels in diabetic rats around 35% with 50 and 100 IU/kg doses sustaining hypoglycemia over 24 h. Pharmacological availability was 5.6 and 3.4% for the 50 and 100 IU/kg doses, respectively, a significant increase over 1.6%, determined for oral insulin alone in solution. Confocal microscopic examinations of FITC-labeled insulin nanoparticles showed adhesion to rat intestinal epithelium, and internalization of insulin within the intestinal mucosa. Encapsulation of insulin into dextran sulfate/chitosan nanoparticles was a key factor in the improvement of the bioavailability of its oral delivery over insulin solution.
Related Papers
- → Chitosan Extraction from Goliathus orientalis Moser, 1909: Characterization and Comparison with Commercially Available Chitosan(2020)17 cited
- → Effect of Chitosan on Shelf Life of Cooked Rice Contaminated Artificially with Bacillus sp(2007)2 cited
- Chitosan 첨가가 Poly(3 - hydroxybutyric acid) 필름의 물리적 특성 및 결정구조에 미치는 영향(2002)
- Chitosan을 이용한 감식초의 청징화(2001)
- 무의 염장과정 중 조직감의 변화에 대한 예열처리 및 Chitosan 첨가효과(1994)